There is controversy as to the existence of effective obesity treatments, the ethical implications of promoting treatments for obesity that do not have long-term follow up data and may have contraindications, and concern that APA's proposed development of Clinical Treatment Guidelines for Obesity may contribute to the structural and institutional discrimination and stigmatization of people of higher weights.